Overcoming Immune System Evasion by Personalized Immunotherapy

Kevin C Soares; Lei Zheng; Nita Ahuja


Personalized Medicine. 2014;11(6):561-564. 

In This Article


In conclusion, cancer's ability to induce tumor tolerance is incredibly complex. Despite promising preclinical studies, durable clinical responses using novel immunotherapeutic agents are lacking. The complexity of cancer care is increasing daily. Future efforts should focus on early detection as well as molecular and genetic/epigenetic characterization of the tumors. Ultimately, these efforts will lead to early diagnosis and personalized, biomarker-driven combinatorial therapies using a variety of medical disciplines.